• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

CHF Solutions Inc.

Nasdaq grants Nuwellis 180-day extension to comply with listing requirement

November 30, 2022 By Sean Whooley

Nuwellis (Nasdaq:NUWE) announced today that the Nasdaq market granted it a 180-day extension to regain compliance. Minneapolis-based Nuwellis must comply with the market’s minimum $1 bid price requirement for continued listing. The extension of 180 calendar days follows the expiration of its initial 180-day period to regain compliance on Nov. 28. As a result, Nuwellis […]

Filed Under: Blood Management, Business/Financial News, Wall Street Beat Tagged With: CHF Solutions Inc., Nuwellis

Nuwellis prices $9.6M upsized offering

October 14, 2022 By Sean Whooley

Nuwellis (Nasdaq:NUWE) announced today that it priced an underwritten public offering worth approximately $9.6 million. The Minneapolis-based fluid overload treatment developer formerly operated as CHF Solutions. Nuwellis is offering preferred stock, common stock and warrants. It expects gross proceeds to total $9.6 million before deducting discounts, commissions and offering expenses, according to a news release. […]

Filed Under: Blood Management, Business/Financial News, Funding Roundup, News Well Tagged With: CHF Solutions Inc., Nuwellis

Nuwellis posts mixed bag Q4

March 1, 2022 By Sean Whooley

Nuwellis (NSDQ:NUWE) shares were up today on fourth-quarter results that were mixed compared to the consensus forecast. The Minneapolis-based fluid overload treatment developer — formerly known as CHF Solutions — posted losses of $4.4 million, or 41¢ per share, on sales of $1.6 million for the three months ended Dec. 31, 2021, for a bottom-line […]

Filed Under: Blood Management, Business/Financial News, Cardiovascular, MassDevice Earnings Roundup, Wall Street Beat Tagged With: CHF Solutions Inc., Nuwellis

Nuwellis wins CE mark for 24-hour blood circuit set for use with Aquadex SmartFlow

September 21, 2021 By Sean Whooley

Nuwellis (NSDQ:NUWE) announced today that it received CE mark approval for its 24-hour blood circuit set for use with the Aquadex SmartFlow. Eden Prairie, Minnesota-based Nuwellis — formerly CHF Solutions — can now market the 24-hour blood circuit set (UF 500-24 Hour) in the European Union and other locations that recognize the CE mark. According […]

Filed Under: Blood Management, Cardiovascular, Featured, Pediatrics, Regulatory/Compliance Tagged With: CE Mark, CHF Solutions Inc., Nuwellis

MedTech 100 roundup: Return to normal following recent spike

May 3, 2021 By Sean Whooley

After back-to-back all-time best performances, the medtech industry had a slight regression over the course of the last week. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — had been continuously ticking up since the beginning of April, with its mark of 112.25 on April 16 representing an all-time […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Abbott, Abiomed, Boston Scientific, Butterfly Network, CHF Solutions Inc., coronavirus, COVID-19, Dexcom, Getinge, MedTech 100 Index, Nuwellis, Proximie, Smith+Nephew, Stryker

CHF Solutions changes name, broadens focus

April 29, 2021 By Sean Whooley

CHF Solutions announced that it has changed its name to Nuwellis to reflect its focus on pediatric care, critical care and heart failure fluid imbalance. Eden Prairie, Minn.–based Nuwellis made the change effective on Tuesday, April 27, 2021, and, in conjunction with the name change, changed its ticker symbol on the Nasdaq from CHFS to […]

Filed Under: Blood Management, Business/Financial News, Cardiovascular, Featured, Pediatrics, Wall Street Beat Tagged With: CHF Solutions Inc., Nuwellis

CHF Solutions prices $18.1M offering

March 17, 2021 By Sean Whooley

CHF Solutions (NSDQ:CHFS) announced today that it priced an underwritten public offering of common stock worth $18.1 million. Eden Prairie, Minn.-based CHF Solutions is offering more than 3.3 million shares of its common stock to the public at $5.50 per share, totaling the $18.1 million expected in proceeds before deducting underwriting discounts and commissions and offering […]

Filed Under: Blood Management, Business/Financial News, Funding Roundup Tagged With: CHF Solutions Inc.

CHF Solutions seeks patent for new Aquadex SmartFlow tech

October 23, 2020 By Sean Whooley

CHF Solutions (NSDQ:CHFS) announced today that it submitted a patent application for a new advance to its Aquadex SmartFlow system. Eden Prairie, Minn.-based CHF Solutions develops Aquadex SmartFlow consoles for removing excess fluid from patients suffering from hypervolemia (fluid overload), which have recently been in demand due to capabilities in treating patients with COVID-19. Get the full […]

Filed Under: Blood Management, Legal News Tagged With: CHF Solutions Inc.

CHF Solutions closes $14.4M offering

August 24, 2020 By Sean Whooley

CHF Solutions (NSDQ:CHFS) announced that it closed an underwritten public offering worth gross proceeds of approximately $14.4 million. Eden Prairie, Minn.-based CHF Solutions’ offering includes the full exercise of the underwriters’ over-allotment option to purchase additional shares and warrants, bringing the total proceeds to $14.37 million after the offering was priced last week at approximately $12.5 […]

Filed Under: Blood Management, Business/Financial News, Cardiovascular, Funding Roundup, Vascular Tagged With: CHF Solutions Inc.

CHF Solutions prices $12.5M offering

August 19, 2020 By Sean Whooley

CHF Solutions (NSDQ:CHFS) announced today that it priced an underwritten public offering of units worth approximately $12.5 million. Each unit in the offering consists of one share of common stock and one warrant to purchase one share of common stock at a public offering price of 45¢ per share, which expires on the fifth anniversary […]

Filed Under: Blood Management, Business/Financial News, Cardiovascular, Featured, Funding Roundup, Vascular Tagged With: CHF Solutions Inc.

MedTech 100 roundup: Another high as stocks tick up

August 10, 2020 By Sean Whooley

For the third consecutive week, stocks in the medtech industry reached heights not yet seen since the COVID-19 pandemic began. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.65 points at the end of last week (Aug. 7). Overall, medtech stocks saw a 0.72% increase from […]

Filed Under: Business/Financial News, Diagnostics, Featured, Funding Roundup, Genomics/Molecular Diagnostics, Initial Public Offering (IPO), MassDevice Earnings Roundup, Mergers & Acquisitions, Pharmaceutical, Research & Development, Wall Street Beat Tagged With: 3m, Abiomed, Acutus Medical, becton dickinson, Cardinal Health, CHF Solutions Inc., coronavirus, COVID-19, DeviceTalks Weekly, Dow Jones, Gilead Sciences, Insulet, Johnson and Johnson, Livongo, MedTech 100 Index, Orthofix, Pfizer, ResMed Inc., S&P, Siemens Healthineers, Teladoc, TransEnterix, Varian Medical Systems

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 5
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy